Kura Oncology Inc (NASDAQ:KURA)
| 12.89 Delayed Data As of Jan 28 |  +0.20 / +1.58%Today’s Change | 11.49 Today|||52-Week Range 35.95 | -7.93% Year-to-Date |
Latest KURA News | Press Releases
No recent news for Kura Oncology Inc.
Today’s Trading
| Previous close | 12.69 |
| Today’s open | 13.79 |
| Day’s range | 12.26 - 12.89 |
| Volume | 35,555 |
| Average volume (3 months) | 658,527 |
| Market cap | $785.4M |
Data as of 4:00pm ET, 01/28/2022
Growth & Valuation
| Earnings growth (last year) | -12.18% |
| Earnings growth (this year) | -19.81% |
| Earnings growth (next 5 years) | +16.24% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 1.28 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| MNKDMannKind Corp | +0.15 | +4.42% |
| ---- | ||
| CRNXCrinetics Pharmaceut... | +0.69 | +4.02% |
| RETAReata Pharmaceutical... | +0.79 | +3.28% |
Data as of 4:00pm ET, 01/28/2022
Financials
| Next reporting date | March 16, 2022 |
| EPS forecast (this quarter) | -$0.54 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$89.6M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters San Diego, California |
Forecasts
